RECRUITING

Assessment Intravenous Site Events During Outpatient Infusion Procedures With a Wireless Thermal Measurement Device During

Description

This study evaluates a Non-invasive Thermal Infusion Site Monitor (NTISM) device when used during routine outpatient infusion treatments.

Conditions

IV InfiltrationIV Extravasation
Talk to us

Related Conditions:

IV InfiltrationIV Extravasation

Study Overview

On this page

Study Details

Study overview

This study evaluates a Non-invasive Thermal Infusion Site Monitor (NTISM) device when used during routine outpatient infusion treatments.

Continuous Monitoring of Intravenous Site Events With a Wireless Thermal Measurement Device During Outpatient Infusion Procedures

Assessment Intravenous Site Events During Outpatient Infusion Procedures With a Wireless Thermal Measurement Device During

Condition
IV Infiltration
Intervention / Treatment

-

Contacts and Locations

Skokie

Infusacare, Skokie, Illinois, United States, 60076

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Scheduled to receive an infusion therapy of at least 30 minutes in length
  • 2. Region of intact skin proximal to the infusion catheter insertion site that is appropriate in size for application of the study device
  • 3. Signed informed consent
  • 4. Available for 15 minutes of post-measurement monitoring following removal of the study device
  • 1. Patient is under 12 years of age
  • 2. Patient-reported history of serious adverse skin reactions to silicone-based adhesives or Tegaderm
  • 3. Use of the study device would interfere with standard patient care that cannot be delayed, or participation in the study will interfere with, or be detrimental to, administration of optimal healthcare to the subject
  • 4. Investigator judges that the intravenous

Ages Eligible for Study

12 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Rhaeos, Inc.,

R. Chad Webb, PRINCIPAL_INVESTIGATOR, Rhaeos, Inc.

Study Record Dates

2025-12